Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-05 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise · Restricted Share Units −21,387 64,164
2022-03-05 Inbar Galia See "Remarks" Option exercise +5,710 15,366
2022-03-05 Inbar Galia See "Remarks" Option exercise · Restricted Share Units −5,710 17,132
2022-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +23,764 135,027.51
2022-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −23,764 71,293
2022-03-05 Drape Eric Executive VP Global Operations Option exercise +22,576 89,406
2022-03-05 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −22,576 67,728
2022-03-05 Dethlefs Sven EVP, North America Commercial Option exercise +24,952 172,374
2022-03-05 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −24,952 74,857
2022-03-05 Daniell Richard Exec. VP, European Commercial Option exercise +22,576 65,758
2022-03-05 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −22,576 67,728
2022-03-04 Weiss Amir Chief Accounting Officer Option exercise +2,403 20,994.41
2022-03-04 Weiss Amir Chief Accounting Officer Option exercise · Restricted Share Units −2,403 2,406
2022-03-04 Weiss Amir Chief Accounting Officer Grant or award · Restricted Share Units +42,707 42,707
2022-03-04 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +37,939 59,319.39
2022-03-04 Stark David Matthew Exec. VP Chief Legal Officer Sale −17,008 $7.48 $127K 42,311.39
2022-03-04 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +13,930 56,241.39
2022-03-04 Stark David Matthew Exec. VP Chief Legal Officer Sale −6,246 $7.48 $47K 49,995.39
2022-03-04 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −37,939 0
2022-03-04 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −13,930 13,931

Page 37 of 76 · 1,517 trades